The National Institute on Drug Abuse is offering a grant to fund research projects investigating the impact of neuroimmune signaling in substance use disorders. This grant aims to explore the role of neuroimmune responses in the development, maintenance, and consequences of SUDs, including abstinence, withdrawal, and relapse. Research proposals should focus on the molecular, cellular, circuit, and behavioral aspects of neuroimmune signaling within the central nervous system. The goal is to better understand how neuroimmune responses may influence the risks and outcomes of SUDs. Application deadline is January 7, 2018.
Opportunity ID: 250835
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-14-084 |
Funding Opportunity Title: | Neuroimmune Signaling in Substance Use Disorders (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Feb 04, 2014 |
Last Updated Date: | Apr 12, 2017 |
Original Closing Date for Applications: | May 07, 2017 |
Current Closing Date for Applications: | Jan 07, 2018 |
Archive Date: | Feb 06, 2018 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Private institutions of higher education Native American tribal governments (Federally recognized) Special district governments For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses County governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of research project grant applications that propose to examine the molecular, cellular, circuit, and behavioral responses to neuroimmune signaling within the central nervous system (CNS) as it pertains to the initiation, escalation, and maintenance of, and the neurological consequences resulting from, substance use disorders (SUDs), and to abstinence and withdrawal from, and subsequent relapse of, drug use. The goal of this understudied area of research is to determine the extent to which neuroimmune responses contribute to or protect against current and future risk and consequences of SUDs. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-14-084.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Updated expiration date in accordance with NOT-DA-17-021 | Apr 12, 2017 | |
Apr 12, 2017 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-14-084 |
Funding Opportunity Title: | Neuroimmune Signaling in Substance Use Disorders (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Feb 04, 2014 |
Last Updated Date: | Apr 12, 2017 |
Original Closing Date for Applications: | May 07, 2017 |
Current Closing Date for Applications: | Jan 07, 2018 |
Archive Date: | Feb 06, 2018 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Private institutions of higher education Native American tribal governments (Federally recognized) Special district governments For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses County governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of research project grant applications that propose to examine the molecular, cellular, circuit, and behavioral responses to neuroimmune signaling within the central nervous system (CNS) as it pertains to the initiation, escalation, and maintenance of, and the neurological consequences resulting from, substance use disorders (SUDs), and to abstinence and withdrawal from, and subsequent relapse of, drug use. The goal of this understudied area of research is to determine the extent to which neuroimmune responses contribute to or protect against current and future risk and consequences of SUDs. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-14-084.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-14-084 |
Funding Opportunity Title: | Neuroimmune Signaling in Substance Use Disorders (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 12, 2017 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 07, 2017 |
Archive Date: | Jun 07, 2017 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | City or township governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) State governments Special district governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) County governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of research project grant applications that propose to examine the molecular, cellular, circuit, and behavioral responses to neuroimmune signaling within the central nervous system (CNS) as it pertains to the initiation, escalation, and maintenance of, and the neurological consequences resulting from, substance use disorders (SUDs), and to abstinence and withdrawal from, and subsequent relapse of, drug use. The goal of this understudied area of research is to determine the extent to which neuroimmune responses contribute to or protect against current and future risk and consequences of SUDs. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-14-084.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.279 | FORMS-C | Forms-C | PKG00192471 | May 05, 2014 | May 07, 2016 | View |
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00222059 | Apr 17, 2016 | Jan 07, 2018 | View |
Package 1
Mandatory forms
250835 RR_SF424_2_0-2.0.pdf
250835 PHS398_ResearchPlan_2_0-2.0.pdf
250835 PHS398_CoverPageSupplement_2_0-2.0.pdf
250835 RR_KeyPersonExpanded_2_0-2.0.pdf
250835 RR_OtherProjectInfo_1_3-1.3.pdf
250835 PerformanceSite_2_0-2.0.pdf
Optional forms
250835 RR_SubawardBudget30_1_3-1.3.pdf
250835 PlannedReport-1.0.pdf
250835 PHS398_CumulativeInclusionReport-1.0.pdf
250835 PHS398_ModularBudget_1_2-1.2.pdf
250835 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
250835 RR_SF424_2_0-2.0.pdf
250835 PHS398_CoverPageSupplement_3_0-3.0.pdf
250835 RR_OtherProjectInfo_1_3-1.3.pdf
250835 PerformanceSite_2_0-2.0.pdf
250835 RR_KeyPersonExpanded_2_0-2.0.pdf
250835 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
250835 RR_Budget_1_3-1.3.pdf
250835 RR_SubawardBudget30_1_3-1.3.pdf
250835 PHS398_ModularBudget_1_2-1.2.pdf
250835 PHS_Inclusion_Enrollment_Report-1.0.pdf
250835 PHS_AssignmentRequestForm-1.0.pdf